| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company focused on fluid management, today announced that stockholders approved all proposals presented at the company's Special Meeting of Stockholders, held virtually earlier today.
Each proposal was designed to enhance the company's financial flexibility and support ongoing strategic growth. The approved items include:
Warrant Exercise Proposal – Stockholders approved the issuance of shares of common stock pursuant to the exercise of warrants sold in the company's June 10, 2025 financing, in accordance with Nasdaq Listing Rule 5635(d). This approval enables Nuwellis to fully access the committed capital from the offering.
Authorized Shares Increase Proposal – Stockholders approved an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of common stock from 100 million to 200 million.
Reverse Split Proposal – Stockholders approved an amendment to the Company's Certificate of Incorporation authorizing a reverse stock split at a ratio between 1-for-5 and 1-for-70, to be enacted at the discretion of the Board of Directors, if necessary, to maintain Nasdaq listing compliance.
Posted In: NUWE
